These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 29445339)

  • 1. Population Pharmacokinetic Modeling of a Desmopressin Oral Lyophilisate in Growing Piglets as a Model for the Pediatric Population.
    Gasthuys E; Vermeulen A; Croubels S; Millecam J; Schauvliege S; van Bergen T; De Bruyne P; Vande Walle J; Devreese M
    Front Pharmacol; 2018; 9():41. PubMed ID: 29445339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of desmopressin administered as tablet and oral lyophilisate formulation in children with monosymptomatic nocturnal enuresis.
    De Bruyne P; De Guchtenaere A; Van Herzeele C; Raes A; Dehoorne J; Hoebeke P; Van Laecke E; Vande Walle J
    Eur J Pediatr; 2014 Feb; 173(2):223-8. PubMed ID: 23989967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Claiming desmopressin therapeutic equivalence in children requires pediatric data: a population PKPD analysis.
    Michelet R; Dossche L; Van Herzeele C; Van Bocxlaer J; Vermeulen A; Vande Walle J;
    Eur J Clin Pharmacol; 2018 Mar; 74(3):297-305. PubMed ID: 29198064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomised comparison of oral desmopressin lyophilisate (MELT) and tablet formulations in children and adolescents with primary nocturnal enuresis.
    Lottmann H; Froeling F; Alloussi S; El-Radhi AS; Rittig S; Riis A; Persson BE
    Int J Clin Pract; 2007 Sep; 61(9):1454-60. PubMed ID: 17655682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric Pharmacology of Desmopressin in Children with Enuresis: A Comprehensive Review.
    Gasthuys E; Dossche L; Michelet R; Nørgaard JP; Devreese M; Croubels S; Vermeulen A; Van Bocxlaer J; Walle JV
    Paediatr Drugs; 2020 Aug; 22(4):369-383. PubMed ID: 32507959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Food and Pharmaceutical Formulation on Desmopressin Pharmacokinetics in Children.
    Michelet R; Dossche L; De Bruyne P; Colin P; Boussery K; Vande Walle J; Van Bocxlaer J; Vermeulen A
    Clin Pharmacokinet; 2016 Sep; 55(9):1159-70. PubMed ID: 27106176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of two sublingual types of desmopressin in 6-year-old and more children with primary nocturnal enuresis. About an international randomized cross-over study].
    Lottmann H
    Prog Urol; 2009 Feb; 19(2):132-8. PubMed ID: 19168019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there still a role for desmopressin in children with primary monosymptomatic nocturnal enuresis?: a focus on safety issues.
    Van de Walle J; Van Herzeele C; Raes A
    Drug Saf; 2010 Apr; 33(4):261-71. PubMed ID: 20297859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased renal concentrating ability after long-term oral desmopressin lyophilisate treatment contributes to continued success for monosymptomatic nocturnal enuresis.
    Ikeda H; Watanabe T; Isoyama K
    Int J Urol; 2017 Sep; 24(9):698-702. PubMed ID: 28636262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of desmopressin administrated as an oral lyophilisate dosage form in children with primary nocturnal enuresis and healthy adults.
    Osterberg O; Savic RM; Karlsson MO; Simonsson US; Nørgaard JP; Walle JV; Agersø H
    J Clin Pharmacol; 2006 Oct; 46(10):1204-11. PubMed ID: 16988210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of long-term efficacy of desmopressin lyophilisate and enuretic alarm for monosymptomatic enuresis and assessment of predictive factors for success: a randomized prospective trial.
    Önol FF; Guzel R; Tahra A; Kaya C; Boylu U
    J Urol; 2015 Feb; 193(2):655-61. PubMed ID: 25158273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desmopressin lyophilisate for the treatment of central diabetes insipidus: first experience in very young infants.
    De Waele K; Cools M; De Guchtenaere A; Van de Walle J; Raes A; Van Aken S; De Coen K; Vanhaesebrouck P; De Schepper J
    Int J Endocrinol Metab; 2014 Oct; 12(4):e16120. PubMed ID: 25745483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral desmopressin lyophilisate (MELT) for monosymptomatic enuresis: structured versus abrupt withdrawal.
    Ferrara P; Romano V; Cortina I; Ianniello F; Fabrizio GC; Chiaretti A
    J Pediatr Urol; 2014 Feb; 10(1):52-5. PubMed ID: 23791016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive parameters of response to desmopressin in primary nocturnal enuresis.
    Van Herzeele C; Evans J; Eggert P; Lottmann H; Norgaard JP; Vande Walle J
    J Pediatr Urol; 2015 Aug; 11(4):200.e1-8. PubMed ID: 26059526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population Pharmacokinetics of Tafenoquine, a Novel Antimalarial.
    Thakkar N; Green JA; Koh GCKW; Duparc S; Tenero D; Goyal N
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30201820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetic analysis of raltegravir pediatric formulations in HIV-infected children 4 weeks to 18 years of age.
    Rizk ML; Du L; Bennetto-Hood C; Wenning L; Teppler H; Homony B; Graham B; Fry C; Nachman S; Wiznia A; Worrell C; Smith B; Acosta EP
    J Clin Pharmacol; 2015 Jul; 55(7):748-56. PubMed ID: 25753401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic properties of infliximab in children and adults with Crohn's disease: a retrospective analysis of data from 2 phase III clinical trials.
    Fasanmade AA; Adedokun OJ; Blank M; Zhou H; Davis HM
    Clin Ther; 2011 Jul; 33(7):946-64. PubMed ID: 21741088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling and Simulation Analysis of Aprepitant Pharmacokinetics in Pediatric Patients With Postoperative or Chemotherapy-Induced Nausea and Vomiting.
    Chain A; Wrishko R; Vasilinin G; Mouksassi S
    J Pediatr Pharmacol Ther; 2020; 25(6):528-539. PubMed ID: 32839657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients.
    El Desoky ES; Sabarinath SN; Hamdi MM; Bewernitz M; Derendorf H
    J Clin Pharm Ther; 2012 Jun; 37(3):352-5. PubMed ID: 21883329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rupatadine Oral Solution Titration by Body Weight in Paediatric Patients Suffering from Allergic Rhinitis: A Population Pharmacokinetic Study.
    Santamaria E; Izquierdo I; Valle M
    Clin Pharmacol; 2021; 13():115-122. PubMed ID: 34135645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.